Quita Highsmith
Director/Board Member at Northwest Kidney Centers
Profile
Quita Highsmith has held positions as Chief Diversity Officer & Vice President at Genentech, Inc. and Trustee at Northwest Kidney Centers.
Quita Highsmith active positions
| Companies | Position | Start |
|---|---|---|
Northwest Kidney Centers
 Northwest Kidney Centers Medical/Nursing ServicesHealth Services Northwest Kidney Centers operates as a non-profit organization. It provides dialysis services. The company was founded in 1962 and id headquartered in Seattle, WA. | Director/Board Member | 2022-07-05 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Northwest Kidney Centers
Northwest Kidney Centers Medical/Nursing ServicesHealth Services Northwest Kidney Centers operates as a non-profit organization. It provides dialysis services. The company was founded in 1962 and id headquartered in Seattle, WA. | Health Services |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Quita Highsmith
